Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Herrstedt, J ^a,c   Roila, F ^b,c  

^a Mental Health Services CPH   (Denmark)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRETAMINE; ANTIEMETIC AGENT; APREPITANT; CARMUSTINE; CHLORMETHINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOLASETRON MESILATE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOXORUBICIN; EPIRUBICIN; GRANISETRON; LORAZEPAM; METHYLPREDNISOLONE; METOCLOPRAMIDE; METOPIMAZINE; ONDANSETRON; OXALIPLATIN; PALONOSETRON; PREDNISOLONE; PROCARBAZINE; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; STREPTOZOCIN; TROPISETRON; UNINDEXED DRUG; ANTINEOPLASTIC AGENT;

ANTICIPATORY NAUSEA AND VOMITING; ARTICLE; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; HUMAN; MEDICAL SOCIETY; MONOTHERAPY; NAUSEA AND VOMITING; PRIORITY JOURNAL; VOMITING; CHEMICALLY INDUCED DISORDER; NAUSEA; PRACTICE GUIDELINE;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; VOMITING;

EID: 45149088259     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn105     Document Type: Article

References (2)

1. The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer: Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.
2. Antiemetic resource center at www.mascc.org.